News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,021 Results
Type
Article (8016)
Company Profile (139)
Press Release (474770)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166763)
Career Advice (305)
Deals (25742)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238249)
Policy (17923)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (480)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33157)
ALS (102)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (253)
Approvals (10329)
Artificial intelligence (307)
ASCO (159)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (103)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (498)
Cancer (3544)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (166)
Celiac Disease (1)
Cell therapy (463)
Cervical cancer (34)
Clinical research (47715)
Collaboration (1196)
Compensation (1386)
Complete response letters (33)
COVID-19 (749)
CRISPR (62)
C-suite (700)
Cystic fibrosis (84)
Data (5481)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (332)
Diagnostics (4140)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (157)
Earnings (72994)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87420)
Executive appointments (677)
FDA (12267)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (886)
Gene editing (123)
Generative AI (9)
Gene therapy (307)
GLP-1 (284)
Government (938)
Grass and pollen (2)
Guidances (278)
Healthcare (9307)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (54)
Indications (149)
Infectious disease (934)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (246)
Interviews (41)
IPO (12378)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5196)
Liver cancer (43)
Longevity (15)
Lung cancer (487)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8628)
Medtech (8745)
Mergers & acquisitions (14347)
Metabolic disorders (685)
mRNA (50)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1775)
NextGen: Class of 2026 (3150)
Non-profit (840)
Obesity (219)
Opinion (10)
Ovarian cancer (155)
Pain (167)
Pancreatic cancer (190)
Parkinson's disease (195)
Partnered (11)
Patents (455)
Patient recruitment (473)
Peanut (31)
People (41106)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15425)
Phase 2 (21306)
Phase 3 (14347)
Pipeline (6600)
Policy (18)
Postmarket research (1570)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (552)
Real estate (3019)
Recruiting (6)
Regulatory (14655)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (147)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (47)
Vaccines (310)
Venture capital (17)
Weight loss (69)
Women's health (73)
Date
Today (45)
Last 7 days (261)
Last 30 days (1070)
Last 365 days (19091)
2026 (10557)
2025 (19251)
2024 (22985)
2023 (26541)
2022 (34594)
2021 (37176)
2020 (33470)
2019 (23275)
2018 (17472)
2017 (18765)
2016 (17917)
2015 (24269)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (227)
Alabama (68)
Alaska (2)
Arizona (290)
Arkansas (11)
Asia (17836)
Australia (2088)
California (11465)
Canada (3037)
China (499)
Colorado (462)
Connecticut (388)
Delaware (201)
Europe (24566)
Florida (1708)
Georgia (363)
Hawaii (2)
Idaho (46)
Illinois (675)
India (40)
Indiana (308)
Iowa (13)
Japan (383)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1146)
Massachusetts (7558)
Michigan (299)
Minnesota (534)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2526)
New Mexico (11)
New York (2724)
North Carolina (1222)
North Dakota (4)
Northern California (5699)
Ohio (263)
Oklahoma (14)
Oregon (16)
Pennsylvania (2185)
Puerto Rico (20)
Rhode Island (29)
South America (405)
South Carolina (75)
South Dakota (1)
Southern California (4757)
Tennessee (113)
Texas (1847)
United States (37318)
Utah (342)
Vermont (1)
Virginia (145)
Washington D.C. (38)
Washington State (890)
West Virginia (1)
Wisconsin (71)
483,021 Results for "sanbio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
SanBio Joins the Newly Formed National TBI Registry Coalition (NTRC) as a Founding Member Organization
The SanBio Group today announced it is one of the founding member organizations of the National TBI Registry Coalition (NTRC) in the United States.
December 15, 2021
·
4 min read
Drug Development
SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623 in Neurology
SanBio Announces Publication of STEMTRA Phase 2 Interim Analysis for SB623 in Neurology Publication Affirms SanBio’s Approach to Treating Chronic Traumatic Brain Injury Patients
January 4, 2021
·
6 min read
Policy
SanBio: Notice Regarding Completion of Approval Filing for Japan SB623 Chronic TBI Program
The SanBio Group hereby announces the completion of an application filing with Japan’s Ministry of Health, Labour, and Welfare for manufacture and marketing approval as a regenerative medicine product for the investigational product SB623, as a treatment for chronic motor deficit from traumatic brain injury.
March 7, 2022
·
5 min read
Biotech Bay
SanBio Announces Publication Comparing Outcome Measures for Persons With Chronic Traumatic Brain Injury in Expert Review of Neurotherapeutics
The SanBio Group, hereby announce that data comparing outcome measures for persons with traumatic brain injury living with chronic motor deficits was published in Expert Review of Neurotherapeutics.
November 1, 2021
·
6 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update
August 19, 2025
·
2 min read
Business
Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases
SanBio Co., Ltd. hereby announces that SanBio has entered into a business alliance with Ocumension Limited.
March 31, 2020
·
3 min read
Press Releases
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio
July 16, 2026
·
3 min read
1 of 48,303
Next
